However, about half of them admitted that fear of insulin-induced hypoglycemia (46.5%) and lack of staff for patient training and education (49.3%) were the main barriers that made them reluctant to prescribe insulin for T2D patients. Here, INS is linked to type 2 diabetes mellitus.